Amgen Inc.

280,33 USD 6,50 (+2,37%)
Bid 279,51 USD
Ask 281,98 USD

Premiumpartner

Firmenbeschreibung

Amgen Inc. zählt weltweit zu den führenden Biotech-Unternehmen. Amgen entwickelt, produziert und vertreibt biopharmazeutische Produkte, die mit Hilfe rekombinanter DNA-Technologien hergestellt werden. Die Forschungsschwerpunkte sind dabei die Hämatologie (Wissenschaft der Blutkrankheiten), Onkologie (Krebsforschung), Nephrologie (Wissenschaft der Nierenkrankheiten), Rheumatologie, Diabetes, Endokrinologie (Lehre der inneren Sekretionsdrüsen), Neurologie und Zelltherapie.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Vanguard Group, Inc. (9.14%),Blackrock Inc. (9.13%),State Street Corporation (5.46%),Primecap Management Company (2.83%),Morgan Stanley (2.4%),Capital Research Global Investors (2.21%),Geode Capital Management, LLC (2.14%),Charles Schwab Investment Management, Inc. (2.01%),Wells Fargo & Company (1.42%),Northern Trust Corporation (1.3%)
sharesOutstanding: 535918901.0000
ceo: Robert Bradway
board: Peter H. Griffith, Annalisa Pizzarello, Anton Rabushka, Arleen Paulino, Darryl Sleep, David A. Piacquad, David M. Reese, Esteban Santos, Gilles Marrache, Ian Thompson, Jean-Charles Soria, Jerry Murry, Jonathan Graham, Judy Gawlik Brown, Lori Johnston, Mark J. Taisey, Mike Zahigian, Murdo Gordon, Nancy Grygiel, Rachna Khosla, Raymond Deshaies, Rob Lenz, Susan Sweeney, Victoria H. Blatter
supervisoryBoard: Robert A. Bradway, Amy E. Miles, Brian J. Druker, Charles M. Holley Jr., Ellen J. Kullman, Greg C. Garland, Michael V. Drake, R. Sanders Williams, Robert A. Eckert, Ronald D. Sugar, S. Omar Ishrak, Tyler Jacks, Wanda M. Austin
countryID: 20
freeFloat: 76.2000
faceValue: 0.0001
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Medizintechnische Produkte
industryName: Gesundheitswesen
subsectorName: Hochentwickelte medizinische Geräte
country: USA
countryName: USA

Kontakt

phone: +1-805-447-1060
email: investor.relations@amgen.com
irWebSite: investors.amgen.com

Adresse

street: One Amgen Center Drive
city: Thousand Oaks, CA 91320-1799, USA
phone: +1-805-447-1000
fax: +1-805-447-1010
webSite: www.amgen.com
email: investor.relations@amgen.com

Finanzen (kurz)

year: 2021 cash: 7989.0000
balanceSheetTotal: 61165.0000 liabilities: 54465.0000
totalShareholdersEquity: 6700.0000 sales: 25979.0000
bankLoans: 7639.0000 investment: 259.0000
incomeBeforeTaxes: 6701.0000 netIncome: 5893.0000
cashFlow: 1723.0000 employees: 24200
currencyID: 4 units: 1000000
currency: USD
year: 2022 cash: 7629.0000
balanceSheetTotal: 65121.0000 liabilities: 61460.0000
totalShareholdersEquity: 3661.0000 sales: 26323.0000
incomeBeforeTaxes: 7346.0000 netIncome: 6552.0000
cashFlow: -360.0000 currencyID: 4
units: 1000000 currency: USD
year: 2023 cash: 10944.0000
balanceSheetTotal: 97154.0000 liabilities: 90922.0000
totalShareholdersEquity: 6232.0000 sales: 28190.0000
incomeBeforeTaxes: 7855.0000 netIncome: 6717.0000
cashFlow: 3315.0000 currencyID: 4
units: 1000000 currency: USD

Finanzen (kurz)

year: 2021
cash: 7989.0000
balanceSheetTotal: 61165.0000
liabilities: 54465.0000
totalShareholdersEquity: 6700.0000
sales: 25979.0000
bankLoans: 7639.0000
investment: 259.0000
incomeBeforeTaxes: 6701.0000
netIncome: 5893.0000
cashFlow: 1723.0000
employees: 24200
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 7629.0000
balanceSheetTotal: 65121.0000
liabilities: 61460.0000
totalShareholdersEquity: 3661.0000
sales: 26323.0000
incomeBeforeTaxes: 7346.0000
netIncome: 6552.0000
cashFlow: -360.0000
currencyID: 4
units: 1000000
currency: USD
year: 2023
cash: 10944.0000
balanceSheetTotal: 97154.0000
liabilities: 90922.0000
totalShareholdersEquity: 6232.0000
sales: 28190.0000
incomeBeforeTaxes: 7855.0000
netIncome: 6717.0000
cashFlow: 3315.0000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 65121.0000 cash: 7629.0000
currentAssets: 22186.0000 fixedAssets: 42935.0000
liabilities: 15687.0000 totalLiabilitiesEquity: 65121.0000
totalShareholdersEquity: 3661.0000 property: 5427.0000
intangibleAssets: 16080.0000 inventories: 4930.0000
accountsReceivable: 5563.0000 accountsPayable: 1572.0000
liabilitiesTotal: 61460.0000 longTermDebt: 37354.0000
shortTermDebt: 1591.0000 sales: 26323.0000
depreciation: 3417.0000 netIncome: 6552.0000
operatingResult: 9566.0000 incomeInterest: -1406.0000
investments: 4434.0000 incomeTaxes: 794.0000
costGoodsSold: 6406.0000 grossProfit: 19917.0000
cashFlow: 9721.0000 cashFlowInvesting: -6044.0000
cashFlowFinancing: -4037.0000 cashFlowTotal: -360.0000
accountingStandard: US GAAP equityRatio: 5.6218
debtEquityRatio: 1678.7763 liquidityI: 48.6326
liquidityII: 84.0951 netMargin: 24.8908
grossMargin: 75.6639 cashFlowMargin: 36.9297
ebitMargin: 36.3408 ebitdaMargin: 0.0000
preTaxROE: 200.6556 preTaxROA: 11.2805
roe: 178.9675 roa: 10.0613
netIncomeGrowth: 11.1828 revenuesGrowth: 1.3241
taxExpenseRate: 10.8086 equityTurnover: 7.1901
epsBasic: 12.1800 epsDiluted: 12.1100
epsBasicGrowth: 17.7950 incomeBeforeTaxes: 7346.0000
priceEarningsRatioCompany: 21.5632 priceCashFlowRatio: 14.4269
dividendYield: 3.0270 bookValuePerShare: 6.8561
marketCap: 140243519148.3200 earningsYield: 4.6375
pegRatio: 1.2118 cashFlowPerShare: 18.2049
priceBookValueRatio: 38.3074 dividendsPerShare: 7.9500
priceEarningsRatio: 21.4047 netEarningsPerShare: 12.2702
currency: USD
year: 2023 units: 1000000
balanceSheetTotal: 97154.0000 cash: 10944.0000
currentAssets: 30332.0000 fixedAssets: 66822.0000
liabilities: 18392.0000 totalLiabilitiesEquity: 97154.0000
totalShareholdersEquity: 6232.0000 property: 5941.0000
intangibleAssets: 32641.0000 inventories: 9518.0000
accountsReceivable: 7268.0000 accountsPayable: 1590.0000
liabilitiesTotal: 90922.0000 longTermDebt: 63170.0000
shortTermDebt: 1443.0000 sales: 28190.0000
depreciation: 4071.0000 netIncome: 6717.0000
operatingResult: 7897.0000 incomeInterest: -2875.0000
investments: 4784.0000 incomeTaxes: 1138.0000
costGoodsSold: 8451.0000 grossProfit: 19739.0000
cashFlow: 8471.0000 cashFlowInvesting: -26204.0000
cashFlowFinancing: 21048.0000 cashFlowTotal: 3315.0000
accountingStandard: US GAAP equityRatio: 6.4146
debtEquityRatio: 1458.9538 liquidityI: 59.5041
liquidityII: 99.0213 netMargin: 23.8276
grossMargin: 70.0213 cashFlowMargin: 30.0497
ebitMargin: 28.0135 ebitdaMargin: 0.0000
preTaxROE: 126.0430 preTaxROA: 8.0851
roe: 107.7824 roa: 6.9138
netIncomeGrowth: 2.5183 revenuesGrowth: 7.0927
taxExpenseRate: 14.4876 equityTurnover: 4.5234
epsBasic: 12.5600 epsDiluted: 12.4900
epsBasicGrowth: 3.1199 incomeBeforeTaxes: 7855.0000
priceEarningsRatioCompany: 22.9315 priceCashFlowRatio: 18.2216
dividendYield: 2.9998 bookValuePerShare: 11.6286
marketCap: 154355361866.0200 earningsYield: 4.3608
pegRatio: 7.3502 cashFlowPerShare: 15.8065
priceBookValueRatio: 24.7682 dividendsPerShare: 8.6400
priceEarningsRatio: 22.9798 netEarningsPerShare: 12.5336
currency: USD
year: 2024 priceEarningsRatioCompany: 22.3193
priceCashFlowRatio: 17.7351 dividendYield: 3.0821
bookValuePerShare: 11.6286 marketCap: 150234145517.3300
earningsYield: 4.4804 pegRatio: 7.1539
cashFlowPerShare: 15.8065 netAssetsPerShare: 11.6286
priceBookValueRatio: 24.1069 priceEarningsRatio: 22.3663
netEarningsPerShare: 12.5336 currency: USD

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 65121.0000
cash: 7629.0000
currentAssets: 22186.0000
fixedAssets: 42935.0000
liabilities: 15687.0000
totalLiabilitiesEquity: 65121.0000
totalShareholdersEquity: 3661.0000
property: 5427.0000
intangibleAssets: 16080.0000
inventories: 4930.0000
accountsReceivable: 5563.0000
accountsPayable: 1572.0000
liabilitiesTotal: 61460.0000
longTermDebt: 37354.0000
shortTermDebt: 1591.0000
sales: 26323.0000
depreciation: 3417.0000
netIncome: 6552.0000
operatingResult: 9566.0000
incomeInterest: -1406.0000
investments: 4434.0000
incomeTaxes: 794.0000
costGoodsSold: 6406.0000
grossProfit: 19917.0000
cashFlow: 9721.0000
cashFlowInvesting: -6044.0000
cashFlowFinancing: -4037.0000
cashFlowTotal: -360.0000
accountingStandard: US GAAP
equityRatio: 5.6218
debtEquityRatio: 1678.7763
liquidityI: 48.6326
liquidityII: 84.0951
netMargin: 24.8908
grossMargin: 75.6639
cashFlowMargin: 36.9297
ebitMargin: 36.3408
ebitdaMargin: 0.0000
preTaxROE: 200.6556
preTaxROA: 11.2805
roe: 178.9675
roa: 10.0613
netIncomeGrowth: 11.1828
revenuesGrowth: 1.3241
taxExpenseRate: 10.8086
equityTurnover: 7.1901
epsBasic: 12.1800
epsDiluted: 12.1100
epsBasicGrowth: 17.7950
incomeBeforeTaxes: 7346.0000
priceEarningsRatioCompany: 21.5632
priceCashFlowRatio: 14.4269
dividendYield: 3.0270
bookValuePerShare: 6.8561
marketCap: 140243519148.3200
earningsYield: 4.6375
pegRatio: 1.2118
cashFlowPerShare: 18.2049
priceBookValueRatio: 38.3074
dividendsPerShare: 7.9500
priceEarningsRatio: 21.4047
netEarningsPerShare: 12.2702
currency: USD
year: 2023
units: 1000000
balanceSheetTotal: 97154.0000
cash: 10944.0000
currentAssets: 30332.0000
fixedAssets: 66822.0000
liabilities: 18392.0000
totalLiabilitiesEquity: 97154.0000
totalShareholdersEquity: 6232.0000
property: 5941.0000
intangibleAssets: 32641.0000
inventories: 9518.0000
accountsReceivable: 7268.0000
accountsPayable: 1590.0000
liabilitiesTotal: 90922.0000
longTermDebt: 63170.0000
shortTermDebt: 1443.0000
sales: 28190.0000
depreciation: 4071.0000
netIncome: 6717.0000
operatingResult: 7897.0000
incomeInterest: -2875.0000
investments: 4784.0000
incomeTaxes: 1138.0000
costGoodsSold: 8451.0000
grossProfit: 19739.0000
cashFlow: 8471.0000
cashFlowInvesting: -26204.0000
cashFlowFinancing: 21048.0000
cashFlowTotal: 3315.0000
accountingStandard: US GAAP
equityRatio: 6.4146
debtEquityRatio: 1458.9538
liquidityI: 59.5041
liquidityII: 99.0213
netMargin: 23.8276
grossMargin: 70.0213
cashFlowMargin: 30.0497
ebitMargin: 28.0135
ebitdaMargin: 0.0000
preTaxROE: 126.0430
preTaxROA: 8.0851
roe: 107.7824
roa: 6.9138
netIncomeGrowth: 2.5183
revenuesGrowth: 7.0927
taxExpenseRate: 14.4876
equityTurnover: 4.5234
epsBasic: 12.5600
epsDiluted: 12.4900
epsBasicGrowth: 3.1199
incomeBeforeTaxes: 7855.0000
priceEarningsRatioCompany: 22.9315
priceCashFlowRatio: 18.2216
dividendYield: 2.9998
bookValuePerShare: 11.6286
marketCap: 154355361866.0200
earningsYield: 4.3608
pegRatio: 7.3502
cashFlowPerShare: 15.8065
priceBookValueRatio: 24.7682
dividendsPerShare: 8.6400
priceEarningsRatio: 22.9798
netEarningsPerShare: 12.5336
currency: USD
year: 2024
priceEarningsRatioCompany: 22.3193
priceCashFlowRatio: 17.7351
dividendYield: 3.0821
bookValuePerShare: 11.6286
marketCap: 150234145517.3300
earningsYield: 4.4804
pegRatio: 7.1539
cashFlowPerShare: 15.8065
netAssetsPerShare: 11.6286
priceBookValueRatio: 24.1069
priceEarningsRatio: 22.3663
netEarningsPerShare: 12.5336
currency: USD